Literature DB >> 18719043

Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report.

M Kuloglu1, A Caykoylu, O Ekinci, E Yilmaz.   

Abstract

Lamotrigine is an anticonvulsant that appears to have a mainly antidepressant effect and is indicated for the maintenance treatment of bipolar depression. Literature associated with obsessional symptoms related to lamotrigine treatment is limited. We report the emergence of obsessive symptoms during treatment with lamotrigine in a patient who subsequently experienced significant improvement after dose reduction and stopping of this medication. The obsessive symptoms associated with lamotrigine treatment were observed after the lamotrigine dose was increased to 100 mg/day. The possible mechanisms, including inhibition on the presynaptic release of glutamate and alteration of striatal dopamine uptake, are discussed. It is unclear why lamotrigine induces obsessions in some patients. Controlled studies are necessary to identify the population at risk for obsessionality in bipolar illness following treatment with lamotrigine and to investigate a possible dose-response relationship between obsessive symptoms and lamotrigine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719043     DOI: 10.1177/0269881108095082

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

1.  Suicidal obsessions as dose dependent side-effect of clozapine.

Authors:  Branka Aukst-Margetić; Branimir Margetić; Vlatka Boricević Marsanić
Journal:  Psychopharmacol Bull       Date:  2011

Review 2.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

3.  Compulsive gambling possibly associated with antiepileptic medication.

Authors:  Susanne Storrier; Roy G Beran
Journal:  Epilepsy Behav Case Rep       Date:  2014-01-08

4.  Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.

Authors:  Alejandro Szmulewicz; Cecilia Samamé; Pablo Caravotta; Diego J Martino; Ana Igoa; Diego Hidalgo-Mazzei; Francesc Colom; Sergio A Strejilevich
Journal:  Int J Bipolar Disord       Date:  2016-02-16

Review 5.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

6.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.